Gastroenterology Report, published by Oxford University Press, is a leading Open Access journal dedicated to advancing the field of gastroenterology. Since its inception in 2013, this journal has become a vital resource for researchers, clinicians, and students, providing them with access to high-quality, peer-reviewed articles that span a wide range of topics in gastrointestinal health and disease. With an impressive Q2 ranking in gastroenterology and holding a position of #66 out of 167 in Scopus rankings, it reflects the growing impact and relevance of its published research. The objective of the Gastroenterology Report is to foster interdisciplinary collaboration and disseminate crucial findings that can improve patient outcomes and shape future studies. As the journal converges its efforts from 2014 to 2024, it continues to strengthen its role as a premier outlet for innovative research and clinical advances in the dynamic field of gastroenterology.

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

Journal of Pediatric Urology is a leading academic journal dedicated to the intersection of pediatric medicine and urological science. Published by ELSEVIER SCI LTD, this esteemed journal provides a vital platform for the dissemination of innovative research and clinical advancements in the field. With a 2023 impact factor that places it within the Q2 quartile for Pediatrics, Perinatology and Child Health, and the Q1 quartile for Urology, it is recognized among the top-tier journals in both domains. The journal covers a broad spectrum of topics from minimally invasive surgical techniques to management strategies for congenital urological disorders. This makes it an invaluable resource for researchers, clinicians, and students who seek to improve pediatric urological care. As the journal continues to evolve, it aims to foster interdisciplinary collaboration that drives further advancements in pediatric health. For those looking to avoid publication barriers, the journal retains traditional access options while contributing to the global growth of pediatric urology research from its base in the Netherlands.

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

Cirugia Cardiovascular is a distinguished open-access journal published by Elsevier, dedicated to advancing the field of cardiovascular surgery and medicine. Established in Spain, this journal serves as a vital platform for disseminating innovative research and clinical insights in the realms of cardiology and surgical practices. With its ISSN 1134-0096 and E-ISSN 1134-0096, Cirugia Cardiovascular has been making impactful contributions to the medical community since becoming an open-access publication in 2005, thus ensuring unrestricted access to critical knowledge. In the most recent evaluation, it was positioned in the Q4 category in both Cardiology and Cardiovascular Medicine and Surgery as of 2023, reflecting its ongoing commitment to improving its scholarly impact. Despite its current ranking within the Scopus database, which highlights its value at percentile ranks of 19th in Surgery and 12th in Cardiology and Cardiovascular Medicine, Cirugia Cardiovascular continues to embrace growth and innovation. The journal aims to unite researchers, clinicians, and students, fostering a collaborative environment to elevate cardiovascular healthcare practices. With a converged year range from 2012 to 2024, it optimally addresses contemporary challenges and advancements in cardiovascular surgical techniques and outcomes.

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.